What are the clinical manifestations of bullous pemphigoid on the hands and feet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Bullous pemphigoid affecting the hands and feet should be treated with superpotent topical corticosteroids as the first line of treatment, according to the European Dermatology Forum consensus 1.

Presentation and Diagnosis

Bullous pemphigoid affecting the hands and feet typically presents as tense, fluid-filled blisters on reddened skin. These blisters can range from small vesicles to large bullae and may be accompanied by intense itching. In the hands, the blisters often appear on the palms and between fingers, while on the feet they commonly develop on the soles and between toes. The condition is an autoimmune disorder where antibodies target proteins in the basement membrane zone of the skin, causing separation between the epidermis and dermis. Diagnosis requires clinical examination, skin biopsy, and immunofluorescence studies.

Treatment Approach

Treatment typically involves:

  • Topical corticosteroids like clobetasol propionate 0.05% applied twice daily for mild cases
  • More extensive disease requires oral corticosteroids (prednisone 0.5-1 mg/kg/day), often combined with steroid-sparing agents such as azathioprine (1-2.5 mg/kg/day), mycophenolate mofetil (1-2 g/day), or doxycycline (100 mg twice daily) 1
  • Proper wound care for ruptured blisters is essential to prevent secondary infections, which may include leaving blisters intact if possible, piercing large blisters with a sterile needle, or using antiseptics such as potassium permanganate for extensive areas of erosion 1
  • Patients should avoid trauma to affected areas and may need pain management for discomfort

Management and Follow-Up

The condition typically requires months of treatment with gradual tapering of medications under medical supervision. A maintenance treatment should be continued for 8 months, with a total treatment duration of 12 months, as recommended by the European Dermatology Forum consensus 1.

From the Research

Bullous Pemphigoid Overview

  • Bullous pemphigoid (BP) is the most frequent auto-immune blistering skin disease 2, 3.
  • It can affect various parts of the body, including the hands and feet.

Treatment of Bullous Pemphigoid

  • Topical corticosteroids, such as clobetasol propionate, have been shown to be effective in treating BP, with fewer systemic side effects compared to oral corticosteroids 2, 4, 3, 5.
  • A study found that whole body application of clobetasol propionate cream can be effective and safe in the induction phase of treatment in mild and severe BP 4.
  • Another study demonstrated that high doses of very potent topical corticosteroids increased initial disease control and 1-year survival of patients with extensive BP, as compared with oral prednisone 6.

Images of Bullous Pemphigoid

  • Unfortunately, there are no images provided in the given studies to illustrate bullous pemphigoid on the hands and feet.
  • However, the studies suggest that topical corticosteroids can be effective in treating BP, regardless of the location of the lesions 2, 4, 3, 5, 6.

Location-Specific Treatment

  • There is no specific information provided in the studies about the treatment of bullous pemphigoid on the hands and feet.
  • However, the studies suggest that topical corticosteroids can be effective in treating BP, regardless of the location of the lesions 2, 4, 3, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of bullous pemphigoid.

The Journal of dermatology, 2003

Research

Whole body application of a potent topical corticosteroid for bullous pemphigoid.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2014

Research

Treatment of bullous pemphigoid with topical clobetasol propionate.

Journal of the American Academy of Dermatology, 1989

Research

[Bullous pemphigoid: a review].

Annales de dermatologie et de venereologie, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.